Cargando…
Intercycle Unplanned Hospital Admissions Due to Cisplatin-based Chemotherapy Regimen-induced Adverse Reactions: A Retrospective Analysis
BACKGROUND: Cisplatin is a commonly used chemotherapy agent known to induce serious adverse reactions that may require hospital readmission. We aimed to analyze the extent and factors associated with unplanned hospital admissions due to cisplatin-based chemotherapy regimen-induced adverse reactions....
Autores principales: | Bright, Heber Rew, Chandy, Sujith J., Chacko, Raju Titus, Backianathan, Selvamani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865053/ https://www.ncbi.nlm.nih.gov/pubmed/31250766 http://dx.doi.org/10.2174/1574886314666190619123047 |
Ejemplares similares
-
Commentary on: “Chronic Use of Hydrochlorothiazide and Risk of Skin Cancer in Caucasian Adults: A PharmLines Initiative Inception Cohort Study”
por: BRIGHT, Heber Rew, et al.
Publicado: (2023) -
Nanotechnology in oncology: Characterization and in vitro release kinetics of cisplatin-loaded albumin nanoparticles: Implications in anticancer drug delivery
por: Das, Saikat, et al.
Publicado: (2011) -
Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay
por: Melado, Laura, et al.
Publicado: (2018) -
Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India
por: Joel, Anjana, et al.
Publicado: (2021) -
Special AT-rich sequence-binding protein 2 (SATB2) in the differential diagnosis of osteogenic and non-osteogenic bone and soft tissue tumors
por: Milton, Sharon, et al.
Publicado: (2022)